CSIMarket
 


Supernus Pharmaceuticals, inc.  (SUPN)
Other Ticker:  
 
 

SUPN's Net Income Growth by Quarter and Year

Supernus Pharmaceuticals, inc.'s Net Income results by quarter and year




SUPN Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 28.01 15.96 61.83
III Quarter September 28.86 30.74 17.37 10.25
II Quarter June 32.73 26.35 10.30 4.83
I Quarter March 25.89 13.66 14.32 6.80
FY   87.48 98.76 57.95 83.71



SUPN Net Income third quarter 2019 Y/Y Growth Comment
Supernus Pharmaceuticals, inc. reported decrease in Net Income in the third quarter by -6.12% to $ 28.86 millions, from the same quarter in 2018.
The decrease in the third quarter Supernus Pharmaceuticals, inc.'s Net Income compares unfavorably to the Company's average Net Income rise of 21.22%.

Looking into third quarter results within Major Pharmaceutical Preparations industry 12 other companies have achieved higher Net Income growth. While Supernus Pharmaceuticals, inc.' s Net Income decline of -6.12% ranks overall at the positon no. 916 in the third quarter.




SUPN Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 75.5 % -74.19 % 1477.3 %
III Quarter September -6.12 % 76.97 % 69.46 % 409.95 %
II Quarter June 24.21 % 155.83 % 113.25 % 425 %
I Quarter March 89.53 % -4.61 % 110.59 % 56.32 %
FY   - 70.42 % -30.77 % 647.41 %

Financial Statements
Supernus Pharmaceuticals, inc.'s third quarter 2019 Net Income $ 28.86 millions SUPN's Income Statement
Supernus Pharmaceuticals, inc.'s third quarter 2018 Net Income $ 30.74 millions Quarterly SUPN's Income Statement
New: More SUPN's historic Net Income Growth >>


SUPN Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - -8.88 % -8.12 % 503.22 %
III Quarter September -11.82 % 16.66 % 68.64 % 112.22 %
II Quarter June 26.42 % 92.9 % -28.07 % -28.97 %
I Quarter March -7.57 % -14.41 % -76.84 % 73.47 %
FY (Year on Year)   - 70.42 % -30.77 % 647.41 %




Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #60
Overall #916

Net Income Y/Y Growth Statistics
High Average Low
220.71 % 21.22 % -68.14 %
(Sep 30 2016)   (Sep 30 2015)
Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #13
Healthcare Sector #60
Overall #916
Net Income Y/Y Growth Statistics
High Average Low
220.71 % 21.22 % -68.14 %
(Sep 30 2016)   (Sep 30 2015)

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Supernus Pharmaceuticals, inc.'s Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
770.02 % 79.13 % -84.37 %
(Sep 30 2014)  


SUPN's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2019 Supernus Pharmaceuticals, inc. realized drop in Net Income from the second quarter by -11.82% to $ 28.86 millions, from $ 32.73 millions released in the previous reporting period.

Although cyclical influence commonly energize III. Quarter 2019 performance, this simply has not been enough to salvage Supernus Pharmaceuticals, inc.'s outcome, Oliver Jackson, Major Pharmaceutical Preparations industry consultant said.

Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Net Income quarter on quarter growth. While Supernus Pharmaceuticals, inc.'s Net Income growth quarter on quarter, overall rank is 1271.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #18
Healthcare Sector #80
Overall #1271
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #18
Healthcare Sector #80
Overall #1271
Net Income Q/Q Growth Statistics
High Average Low
770.02 % 79.13 % -84.37 %
(Sep 30 2014)  


SUPN's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2019 Supernus Pharmaceuticals, inc. reported drop in Net Income sequentially by -11.82% to $ 28.86 millions, from $ 32.73 millions declared in the previous reporting period.

Some seasonal influence could not rescue the III. Quarter for the Supernus Pharmaceuticals, inc., Oliver Jackson, Major Pharmaceutical Preparations industry consultant wrote, he mentioned some pessimism towards Supernus Pharmaceuticals, inc.'s outlook and wrote that average sequential Net Income growth is at 79.13% for Supernus Pharmaceuticals, inc..

Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Net Income quarter on quarter growth. While Supernus Pharmaceuticals, inc.'s Net Income growth quarter on quarter, overall rank is 1271.


Supernus Pharmaceuticals, inc.'s 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Net Income 12 Months Ending $ 115.49 $ 117.37 $ 110.99 $ 98.76 $ 86.71
Y / Y Net Income Growth (TTM) 33.2 % 60.03 % 93.76 % 70.43 % -16.47 %
Year on Year Net Income Growth Overall Ranking # 595 # 481 # 461 # 470 # 1297
Seqeuential Net Income Change (TTM) -1.6 % 5.74 % 12.39 % 13.9 % 18.23 %
Seq. Net Income Growth (TTM) Overall Ranking # 1246 # 726 # 980 # 548 # 571




Cumulative Net Income growth Comment
With the quarterly Net Income reported in the Sep 30 2019 period, Supernus Pharmaceuticals, inc.'s cumulative twelve months Net Income were $ 115 millions, company would post below average annual Net Income growth of 18.23% year on year, if the fiscal year would end at Sep 30 2019.
A slow-down in the Supernus Pharmaceuticals, inc.'s Net Income growth from the 32.73% growth in Jun 30 2019.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 481 to 595.

Net Income TTM Q/Q Growth Statistics
High Average Low
220.71 %
21.22 %
-68.14 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 59
Overall # 595

Net Income TTM Y/Y Growth Statistics
High Average Low
627.98 %
132.81 %
-50.66 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 85
S&P 500 # 1246
Cumulative Net Income growth Comment
With the quarterly Net Income reported in the Sep 30 2019 period, Supernus Pharmaceuticals, inc.'s cumulative twelve months Net Income were $ 115 millions, company would post below average annual Net Income growth of -50.66% year on year, if the fiscal year would end at Sep 30 2019.
A slow-down in the Supernus Pharmaceuticals, inc.'s Net Income growth from the 32.73% growth in Jun 30 2019.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 481 to 595.

Net Income TTM Q/Q Growth Statistics
High Average Low
220.71 %
21.22 %
-68.14 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 59
Overall # 595

Net Income TTM Y/Y Growth Statistics
High Average Low
627.98 %
132.81 %
-50.66 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 85
S&P 500 # 1246




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
SUPN's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for SUPN's Competitors
Net Income Growth for Supernus Pharmaceuticals, inc.'s Suppliers
Net Income Growth for SUPN's Customers

You may also want to know
SUPN's Annual Growth Rates SUPN's Profitability Ratios SUPN's Asset Turnover Ratio SUPN's Dividend Growth
SUPN's Roe SUPN's Valuation Ratios SUPN's Financial Strength Ratios SUPN's Dividend Payout Ratio
SUPN's Roa SUPN's Inventory Turnover Ratio SUPN's Growth Rates SUPN's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2019
Quest Diagnostics Inc -0.44 %$ -0.441 millions
Dexcom, Inc. -1.72 %$ -1.717 millions
Merck & Co., Inc. -2.60 %$ -2.605 millions
Procyon Corp -3.94 %$ -3.941 millions
Innoviva, inc. -6.21 %$ -6.211 millions
Radnet, Inc. -11.80 %$ -11.796 millions
Masimo Corp -14.08 %$ -14.076 millions
Hca Healthcare, Inc. -14.73 %$ -14.732 millions
Bio-techne Corp -17.27 %$ -17.267 millions
Pro Dex Inc -18.16 %$ -18.162 millions
Stryker Corp -21.02 %$ -21.017 millions
Zynex Inc -21.54 %$ -21.536 millions
Magellan Health, inc. -21.63 %$ -21.628 millions
Ani Pharmaceuticals Inc -22.67 %$ -22.672 millions
Exelixis, Inc. -23.04 %$ -23.042 millions
Bristol Myers Squibb Co -28.56 %$ -28.556 millions
Healthcare Services Group, Inc. -29.68 %$ -29.679 millions
Laboratory Corp Of America Holdings -30.72 %$ -30.721 millions
Nuvasive Inc -30.85 %$ -30.855 millions
Jazz Pharmaceuticals Plc -31.50 %$ -31.504 millions
Standard Diversified Inc. -36.36 %$ -36.364 millions
Petmed Express Inc -38.01 %$ -38.012 millions
Techcare Corp. -38.18 %$ -38.184 millions
Amphastar Pharmaceuticals, Inc. -39.11 %$ -39.109 millions
Universal Health Services Inc -42.32 %$ -42.321 millions
Tivity Health, Inc. -45.10 %$ -45.104 millions
Utah Medical Products Inc -45.21 %$ -45.209 millions
Jrsis Health Care Corp -46.24 %$ -46.238 millions
Psychemedics Corp -46.90 %$ -46.902 millions
Biotelemetry, Inc. -48.23 %$ -48.234 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DHX's Profile

Stock Price

DHX's Financials

Business Description

Fundamentals

Charts & Quotes

DHX's News

Suppliers

DHX's Competitors

Customers & Markets

Economic Indicators

DHX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071